Miguel Tam, Director of Strategic Marketing at Revvity’s BioLegend, explores the future directions and applications of flow cytometry in drug discovery, highlighting the opportunities it presents and the challenges that lie ahead  Flow cytometry has long been a cornerstone in biomedical research and clinical diagnostics, offering unparalleled capabilities to analyse multiple parameters of single cells […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!